What is the Fiscal Year for Northwest Biotherapeutics?
Date: November 13, 2026
Northwest Biotherapeutics's current fiscal year starts on January 1, 2025, and ends on December 31, 2025. Their current quarter is Q4, which ends on December 31, 2025.
Current Fiscal Year Overview
Fiscal Year Start
January 1, 2025
Fiscal Year End
December 31, 2025
Current Quarter
Q4
Current Quarter End
December 31, 2025
Quarterly Breakdown
Q1
Jan 1, 2025 – Mar 31, 2025
Q2
Apr 1, 2025 – Jun 30, 2025
Q3
Jul 1, 2025 – Sep 30, 2025
Q4
Oct 1, 2025 – Dec 31, 2025
Company Information
Headquarters
Bethesda, MD
Industry
Biotechnology Research
Stock Symbol
NWBO
Website
http://nwbio.comDescription
Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer.
Use Salesmotion for Account Data and Insights
Sales professionals can use Salesmotion to access comprehensive account intelligence and automate their research. Instantly get insights on companies like Northwest Biotherapeutics and uncover key business information that drives smarter conversations.
Book a demo today to strengthen your sales strategy with powerful data and actionable insights.